Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Viavi Solutions (VIAV) Research & Development (2016 - 2025)

Viavi Solutions (VIAV) has disclosed Research & Development for 17 consecutive years, with $65.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Research & Development rose 26.49% year-over-year to $65.9 million, compared with a TTM value of $229.1 million through Dec 2025, up 12.3%, and an annual FY2025 reading of $208.7 million, up 3.37% over the prior year.
  • Research & Development was $65.9 million for Q4 2025 at Viavi Solutions, up from $56.0 million in the prior quarter.
  • Across five years, Research & Development topped out at $65.9 million in Q4 2025 and bottomed at $49.4 million in Q3 2024.
  • Average Research & Development over 5 years is $52.7 million, with a median of $52.1 million recorded in 2021.
  • The sharpest move saw Research & Development decreased 7.47% in 2023, then grew 26.49% in 2025.
  • Year by year, Research & Development stood at $53.6 million in 2021, then decreased by 3.17% to $51.9 million in 2022, then decreased by 4.62% to $49.5 million in 2023, then increased by 5.25% to $52.1 million in 2024, then grew by 26.49% to $65.9 million in 2025.
  • Business Quant data shows Research & Development for VIAV at $65.9 million in Q4 2025, $56.0 million in Q3 2025, and $57.2 million in Q2 2025.